Paricalcitol regulatory effect on inflammatory, fibrotic and anticalcificating parameters in renal patient. Far beyond mineral bone disease regulation Laura Salanova Villanueva; Yohana Gil Giraldo; Begoña Santos Sánchez-Rey; Abelardo Aguilera Peralta;

Etelcalcetide controls secondary hyperparathyroidism and raises sclerostin levels in hemodialysis patients previously uncontrolled with cinacalcet Luciano Artur Lopes Pereira; Catarina Meng; Manuel Augusto Gonçalves Amoedo; Maria Teresa de Sousa Costa Pinto Ferreira Mendes; Marco Alexandre Mateus Prazeres Marques; João Miguel Machado Dória Frazão; André Luiz Loureiro Weigert;

Inflammation and hemodialysis adequacy: are C-reactive protein levels influenced by the dose of dialysis? Francisco Valga; Tania Monzón; Nicanor Vega-Diaz; José Carlos Rodriguez-Perez; Sergio Ruiz-Santana;